A
AVIPERO is developing allosteric modulators of integrins to enhance tissue repair and address age-related diseases. Their technology targets integrin pathways to improve healing processes and mitigate the effects of aging on tissue function.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- AVIPERO is developing allosteric modulators of integrins to enhance tissue repair and address age-related diseases. Their technology targets integrin pathways to improve healing processes and mitigate the effects of aging on tissue function.